A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency Syndrome

New England Journal of Medicine

Volumn 325, Issue 8, 1991, Pages 551-555

  Safrin, Sharon ^a   Crumpacker, Clyde ^b   Chatis, Pam ^b   Davis, Roger ^c   Hafner, Richard ^d   Rush, Joanne ^a   Kessler, Harold A ^e   Landry, Bernard ^d   Mills, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FOSCARNET; VIDARABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESISTANCE; DRUG THERAPY; DRUG TOXICITY; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; COMPARATIVE STUDY; DRUG RESISTANCE, MICROBIAL; FEMALE; FOSCARNET; HERPES GENITALIS; HUMAN; MALE; PHOSPHONOACETIC ACID; RECURRENCE; SIMPLEXVIRUS; STOMATITIS, HERPETIC; VIDARABINE;

EID: 0025896084     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199108223250805     Document Type: Article

References (30)

1. Vinckier F., Boogaerts M., De Clerck D., De Clercq E. Chronic herpetic infection in an immunocompromised patient: report of a case. J Oral Maxillofac Surg 1987; 45:723-8
2. Norris S.A., Kessler H.A., Fife K.H. Severe, progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS. J Infect Dis 1988; 157:209-10
3. Youle M.M., Hawkins D.A., Collins P., et al. Acyclovir-resistant herpes in AIDS treated with foscarnet. Lancet 1988; 2:341-2
4. Erlich K.S., Mills J., Chatis P., et al. Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 1989; 320:293-6
5. Marks G.L., Nolan P.E., Erlich K.S., Ellis M.N. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS. Rev Infect Dis 1989; 11:474-6
6. Safrin S., Assaykeen T., Follansbee S., Mills J. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data. J Infect Dis 1990; 161:1078-84
7. Gateley A., Gander R.M., Johnson P.C., Kit S., Otsuka H., Kohl S. Herpes simplex type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J Infect Dis 1990; 161:711-5
8. Birch C.J., Tachedjian G., Doherty R.R., Hayes K., Gust I.D. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. J Infect Dis 1990; 162:731-4
9. Chatis P.A., Miller C.H., Schrager L.E., Crumpacker C.S. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. N Engl J Med 1989; 320:297-300
10. Whitley R.J., Soong S.-J., Dolin R., et al. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study. N Engl J Med 1977; 297:289-94
11. Whitley R.J., Nahmias A.J., Soong S.-J., Galasso G.G., Fleming C.L., Alford C.A. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1989; 66:495-501
12. Whitley R.J., Spruance S. Hayden FG, et al. Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host. J Infect Dis 1984; 149:1-8
13. Erlich K.S., Jacobson M.A., Koehler J.E., et al. Foscarnet therapy of severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110:710-3
14. Jacobson M.A., O#x0027;Donnell J.J., Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrob Agents Chemother 1989; 33:736-41
15. Drew W.L., Rawls W.E. Herpes simplex viruses. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985: 705-10
16. Ellis M.N., Keller P.M., Fyfe J.A., et al. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother 1987; 31:1117-25
17. Jamieson A.T., Gentry G.A., Subak-Sharpe J.H. Induction of both thymidine and deoxycytidine kinase activity by herpes viruses. J Gen Virol 1974; 24:465-80
18. Ch#x0027;ien L.T., Whitley R.J., Alford C.A. Jr., Galasso G.J. Adenine arabinoside for therapy of herpes zoster in immunosuppressed patients: preliminary results of a collaborative study. J Infect Dis 1976; 133:Suppl:A184-A191
19. Sacks S.L., Smith J.L., Pollard R.B., et al. Toxicity of vidarabine. JAMA 1979; 241:28-9
20. Van Etta L.V., Brown J., Mastri A., Wilson T. Fatal vidarabine toxicity in a patient with normal renal function. JAMA 1981; 246:1703-5
21. Lauter C.B., Bailey E.J., Lerner A.M. Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans. J Infect Dis 1976; 134:75-9
22. Burdge D.R., Chow A.W., Sacks S.L. Neurotoxic effects during vidarabine therapy for herpes zoster. Can Med Assoc J 1985; 132:392-5
23. Ross A.H., Julia A., Balakrishnan C. Toxicity of adenine arabinoside in humans. J Infect Dis 1976; 133:Suppl:AI92-A198
24. Sacks S.L., Scullard G.H., Pollard R.B., Gregory P.B., Robinson W.S., Merigan T.C. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. Antimicrob Agents Chemother 1982; 21:93-100
25. Marker S.C., Howard R.J., Groth K.E., Mastri A.R., Simmons R.L., Balfour H.H. A trial of vidarabine for cytomegalovirus infection in renal transplant patients. Arch Intern Med 1980; 140:1441-4
26. Feldman S., Robertson P.K., Lott L., Thornton D. Neurotoxicity due to adenine arabinoside therapy during varicella–zoster virus infections in immunocompromised children. J Infect Dis 1986; 154:889-93
27. Whitley R.J., Tucker B.C., Kinkel A.W., et al. Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother 1980; 18:709-15
28. Sacks S.L., Wanklin R.J., Reece D.E., Hicks K.A., Tyler K.L., Coen D.M. Progressive esophagitis from acyclovir-resistant herpes simplex: clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med 1989; 111:893-9
29. Parker AC, Craig J.I.O., Collins P., Oliver N., Smith I. Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase. Lancet 1987; 2:1461
30. Collins P., Larder B.A., Oliver N.M., Kemp S., Smith I.W., Darby G. Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol 1989; 70: 375-82